Addiction care is not separate from psychiatric care. In community practice, psychiatrists may encounter substance use disorders and behavioral addictions alongside depression, anxiety, PTSD, ADHD, bipolar disorder, psychotic disorders, and other psychiatric conditions. This carousel highlights four practical areas to keep in mind: 🔹 Screen — Make substance use screening part of your routine assessment. 🔹 Assess — Look for co-occurring psychiatric conditions and suicide risk. 🔹 Treat — Know the evidence-based treatment options available. 🔹 Refer & Follow Up — Recognize when specialized addiction care is needed and remain involved in the patient's ongoing psychiatric care. A key clinical reminder: Don't evaluate addiction in isolation. Look at the whole clinical picture. For clinicians, being comfortable recognizing and addressing addiction can make a meaningful difference in comprehensive psychiatric care. 🎓 Ready to Take Your Psychiatry Skills Further? If you want to move beyond memorizing medications and develop a stronger framework for clinical reasoning, diagnosis, and treatment decisions, Psych Mastery With Dr. Mena gives you a structured way to keep building those skills. ⭐ PREMIUM — $199/month or $1,500/year Get full access to the Psychiatry Masterclass with Dr. Mena, including: ✅ All 14 modules ✅ Video lessons and course materials ✅ Downloadable slides and handouts ✅ Comprehensive psychiatry education ✅ Practical concepts to strengthen clinical reasoning and psychiatric decision-making 🔥 VIP — $500/month or $3,500/year For clinicians who want a more personalized learning experience: Everything in Premium, PLUS: ✅ 1:1 mentorship with Dr. Mena focused on business, branding, and clinical practice ✅ Weekly case discussions ✅ Personalized mentorship and professional guidance Whether you're a PMHNP student, newer psychiatric clinician, or experienced provider, Psych Mastery With Dr. Mena is built to help you keep developing your psychiatric knowledge and apply it more confidently to real-world clinical situations.

Adult ADHD is becoming an increasingly important part of psychiatric practice, but diagnosing and treating ADHD in adults requires more than identifying problems with focus. The new U.S. Adult ADHD Guidelines are currently in their final review stage, with publication anticipated in fall 2026. For PMHNPs and psychiatric clinicians, this is a good time to revisit the fundamentals. When evaluating an adult for possible ADHD, clinicians should consider: 🧠 Clinical history — Is there evidence of symptoms beginning in childhood, and how have they affected the patient's functioning over time? 🔍 Differential diagnosis — Could anxiety, depression, sleep disorders, substance use, or another condition better explain the symptoms? 📋 Functional impairment — How are symptoms affecting work, relationships, daily responsibilities, and other areas of life? 💊 Treatment options — When should medication be considered, and what factors should guide the choice of treatment? 🤝 Individualized care — How should treatment be adapted based on comorbidities, patient preferences, risks, and clinical response? 📈 Ongoing monitoring — How should clinicians assess treatment response, adverse effects, and changes in functioning over time? The goal isn't simply to recognize ADHD. The goal is to diagnose it accurately, distinguish it from overlapping conditions, and treat the whole patient. 💭 Clinical Question What is the most challenging part of evaluating or treating adult ADHD in your clinical practice? Share your experience in the comments. 👇 🎓 Want to Strengthen Your Psychiatry Clinical Reasoning? If you're looking to go beyond simply memorizing medications and develop a stronger understanding of how to approach complex psychiatric cases, check out Psych Mastery With Dr. Mena. ⭐ PREMIUM — $199/month or $1,500/year Get full access to the Psychiatry Masterclass with Dr. Mena, including: ✅ All 14 modules ✅ Video lessons and course materials ✅ Downloadable slides and handouts ✅ Comprehensive psychiatry education

What if the challenge in bipolar treatment isn't always that the medication doesn't work—but that the patient isn't receiving it consistently? For some patients, maintaining a daily medication routine can be difficult. Treatment gaps can contribute to relapse, hospitalization, and disruption in functioning. This is where long-acting injectable (LAI) antipsychotics may offer another treatment option. But the question isn't simply: “Should we use an LAI?” The better clinical question is: “Which patients are most likely to benefit?” When considering an LAI for a patient with bipolar disorder, clinicians should think about: 🧠 Clinical history — Previous episodes, relapse patterns, and history of medication nonadherence 💊 Medication response — Has the patient responded well to and tolerated the oral formulation? 📋 Treatment history — What has worked, what hasn't, and why? 🤝 Patient preference — Is the patient comfortable with an injectable treatment and its schedule? 📅 Practical considerations — Can the patient reliably attend injection appointments? ⚖️ Risk–benefit considerations — What are the medication-specific adverse effects, monitoring requirements, and individual risk factors? The goal isn't simply to improve adherence. The goal is to create a sustainable treatment strategy that supports long-term stability, functioning, and quality of life. LAIs shouldn't automatically be viewed as a “last resort.” For appropriately selected patients, they can be an important part of a comprehensive bipolar maintenance strategy. 💭 Clinical Question When do YOU consider an LAI for a patient with bipolar disorder? What factors influence your decision? Share your clinical perspective and experience in the comments. 👇 🎓 Want to Strengthen Your Psychiatry Clinical Reasoning? If you're looking to go beyond simply memorizing medications and instead develop a stronger understanding of how to think through complex psychiatric cases, check out Psych Mastery With Dr. Mena. ⭐ PREMIUM — $199/month or $1,500/year